Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Grifols, S.A.

https://www.grifols.com/

Latest From Grifols, S.A.

Grifols Aims For Largely Untapped Market With Successful Fibrinogen Deficiency Study

The Phase III trial of BT524 produced positive topline results in patients with acquired fibrinogen deficiency, potentially making it the first fibrinogen concentrate to win US FDA approval for that indication.

Clinical Trials Blood & Coagulation Disorders

Scrip Asks…What Does 2024 Hold For Biopharma? Part 6: Therapeutic Area Advances

More than 100 biopharma executives and experts told Scrip their predictions for therapeutic area advances in the coming year. The recent commercial success of GLP-1s in diabetes and obesity and their potential in further disease areas fuelled excitement around the metabolic space. Expectations were also positive in neurology following the launch of Leqembi for Alzheimer’s disease in 2023, while the multiple opportunities to improve cancer treatment kept oncology top of the pile overall.

Scrip Asks Advanced Therapies

CTAD 2023: Grifols/Araclon Ponder Next Steps For ABvac40 After Phase II Readout

The Phase II trial was not powered to show statistical significance on cognitive efficacy, but early Alzheimer’s patients treated with Araclon/Grifols’ anti-Aβ40 vaccine had slower decline by some measures.

Clinical Trials Neurology

Schizophrenia, Depression And Neuropathy: What’s Coming In 2024

The following four neurological products are likely to reach market next year. Carving out sales will be an entirely different problem. 

Approvals Neurology
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Medical Devices
    • Diagnostic Equipment & Supplies
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Other Names / Subsidiaries
    • Alpha Therapeutic Corporation
    • Biotest AG
    • Goetech LLC
    • GigaGen, Inc.
    • Grifols Therapeutics, Inc.
    • MedKeeper
    • Talecris Biotherapeutics Inc.
    • Haema AG.
UsernamePublicRestriction

Register